ACHN Financial Facts
Loss from operations: -11.79MTotal operating expenses: 11.79M
See Full Income Statement
Restricted cash: 152K
Accumulated deficit: -334.47M
See Full Balance Sheet
Earnings History for Achillion Pharmaceuticals, Inc. (ACHN)
|
Expand Research on ACHN
| Next EPS Date | 8/7/13 *Est. | EPS Growth Rate | -7.7% *Last Qtr. |
|---|---|---|---|
| Average EPS % Beat Rate | +2.1% | Revenue Growth Rate | -100.0% *Last Qtr. |
| Average % Move 1-Wk after EPS | -5.4% |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Estimize EPS/Revs | Gd. | % Since | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 5/7/13 | Q113 | -$0.14 | -$0.15 | +$0.01 | N/A | N/A | N/A / N/A | N/A | +10.4% | Details | |
| 11/8/12 | Q312 | -$0.20 | -$0.17 | -$0.03 | N/A | $50K | N/A / N/A | = | -11.5% | Details | |
| 8/8/12 | Q212 | -$0.16 | -$0.17 | +$0.01 | N/A | $60K | N/A / N/A | = | +12.2% | Details | |
5/8/12  |
Q112 | -$0.13 | -$0.15 | +$0.02 | $2.5M | $1.06M | N/A / N/A | = | +20% | Details | |
| 3/8/12 | Q411 | -$0.18 | -$0.16 | -$0.02 | $62K | $120K | N/A / N/A | = | -24.3% | Details | |
| 11/8/11 |
Q311 | -$0.15 | -$0.16 | +$0.01 | $64K | $130K | N/A / N/A | = | +27.7% | Details | |
| 5/4/11 |
Q111 | -$0.17 | -$0.14 | -$0.03 | $65K | $180K | N/A / N/A | = | +45.5% | Details | |
| 3/2/11 | Q410 | -$0.11 | -$0.13 | +$0.02 | $2.01M | $380K | N/A / N/A | = | +30.5% | Details |
